10.1016/j.cmet.2017.11.003 [DOI] [PubMed] [Google Scholar] Wallner M, Kolesnik E, Ablasser K, Khafaga M, Wakula P, Ljubojevic S, Thon-Gutschi EM, Sourij H, Kapl M, Edmunds NJ, Kuzmiski JB, Griffith DA, Knez I, Pieske B, von Lewinski D (2015) Exenatide exerts a PKA-dependent positive inotropic effect in human atrial myocardium: GLP-1R mediated effects in human myocardium
Same total calories, dramatically different comfort level
Compared to popular GLP-1RAs like semaglutide, orforglipron does not require injection or an absorption enhancer with fasting to achieve exposure, and it can be taken without water or food restrictions, according to Phase 1 pharmacokinetic data
A healthcare provider will assess suitability
Beyond the efficacy data, the company is positioning elecoglipron as a cornerstone of its broader cardiovascular, renal and metabolism (CVRM) strategy, with plans to explore both monotherapy and combination approaches
, ( )